The DOI matches its Crossref record; 52 of the 54 references it cites were found in a registry or an index, and 2 are not checked yet; none of the 12 sources its claims cite is checked for support yet.
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Open accessAbstract
Following its emergence in late 2019, the spread of SARS-CoV-2 1,2 has been tracked by phylogenetic analysis of viral genome sequences in unprecedented detail 3-5. Although the virus spread globally in early 2020 before borders closed, intercontinental travel has since been greatly reduced. However, travel within Europe resumed in the summer of 2020. Here we report on a SARS-CoV-2 variant, 20E (EU1), that was identified in Spain in early summer 2020 and subsequently spread across Europe. We find no evidence that this variant has increased transmissibility, but instead demonstrate how rising incidence in Spain, resumption of travel, and lack of effective screening and containment may explain the variant's success. Despite travel restrictions, we estimate that 20E (EU1) was introduced hundreds of times to European countries by summertime travellers, which is likely to have undermined local efforts to minimize infection with SARS-CoV-2. Our results illustrate how a variant can rapidly become dominant even in the absence of a substantial transmission advantage in favourable epidemiological settings. Genomic surveillance is critical for understanding how travel can affect transmission of SARS-CoV-2, and thus for informing future containment strategies as travel resumes.
Checked 2026-10-06 · 2 references not checked yet
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
41 Own result · 24 Own interpretation · 11 Own method · 8 Not checked yet · 7 No basis given
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Norway and Iceland, for example, seem to have only a small number of introductions over the summer that led to substantial further spread.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, countries like Switzerland, the Netherlands, or the United Kingdom have sampled sequences that correspond to a large number of independent introductions that include most major genotypes observed in Spain.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Most basal genotypes have been observed both in Spain and a large number of other countries, suggesting repeated exports.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Sequences from Hong Kong, Australia, New Zealand, and Singapore, presumably exports from Europe, were first detected between mid-August and mid-October (see Supplementary Table I).”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Early observations of 20E (EU1)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The dose-response curves were indistinguishable for the SARS-CoV-2 2PS and the SARS-CoV-2 2P A222V D614G S ectodomain trimers (observed by ELISA, Fig. ED3a-d)”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Characterization of S:A222V
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In many European countries, we observe a gradual rise starting in mid-July before settling at a level between 15 and 80% in September or October.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Early observations of 20E (EU1)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Several other smaller clusters defined by the spike mutations D80Y, S98F, N439K are also seen in multiple countries (see Table ED I and Fig. ED1).”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In addition to S:A222V, 20E (EU1) has the amino acid mutations ORF10:V30L, N:A220V and ORF14:L67F.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Characterization of S:A222V
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Epidemiological data from Spain indicates the earliest sequences in the cluster are associated with two known outbreaks in the north-east of the country.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By the end of August, 20E (EU1) also included sequences from Belgium, Switzerland, France, Denmark, the UK, Germany, Latvia, Sweden, Norway and Italy.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Early observations of 20E (EU1)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 38
- Probably not a substantial claim. 8
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The tree indicates that 20E (EU1) harbors substantial diversity and most major genotypes have been observed in many European countries.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In Fig. ED4a, the majority of sequences from these countries fall into one sector, the remainder are singletons or very small clusters that have not spread.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Throughout July and August 2020, Spain had a higher per capita incidence than most other European countries (see Fig ED5) and 20E (EU1) was much more prevalent in Spain then elsewhere, suggesting Spain as likely origin of most 20E (EU1) introductions to other countries.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Lentiviral particles with the A222V mutant spike had slightly higher titers than those without (mean 1.3-fold higher), although the difference was not statistically significant after normalization by p24 concentration (Fig. ED3e-h).”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Characterization of S:A222V
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“20E (EU1) first rose in frequency in Spain, jumping to around 50% prevalence within a month of the first sequence being detected before rising to 80%.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Early observations of 20E (EU1)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“S:N439K is present in two larger clusters found across Europe 19 and arose several times independently.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Abstract
What the sources say
- Not checked yetcites [19] Thomson, E. C. et al. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell 184, 1171–1187 (2021). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Similarly, for Germany and Switzerland we would expect around 320 and 90 introductions of 20E (EU1), respectively.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Returning tourists have a similar SARS-CoV-2 incidence to the reported provincial incidence in Spain.
- The authors state this as an assumption: Reported provincial incidence in Spain is accurate and representative for the import model.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While there is little data to inform estimates of R e for 20E (EU1) in July and it differs little from the prior, there is some evidence that 20E (EU1) was growing faster than other variants in August.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A novel variant (orange; 20E (EU1)) with mutation S:A222V on a S:D614G background emerged in early summer and is common in most countries with recent sequences.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There were also a small number of larger transmission chains including more than 53 transmissions (20 across all data sets) which are not shown in the histograms.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After p24 normalization, the titer difference shrinks fom 1.28 to 1.14 fold, increasing the p-value to 0.16.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Pseudotyped Lentivirus Production and Titering
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The number of confirmed SARS-CoV-2 cases in Spain rose from around 10 cases per 100k inhabitants per week in early July to 100 in late August, while case numbers remained low in most of Europe during this time.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Notably, the peak in August in the Swiss analysis is larger under the 'min' definition (f) than under the 'max' definition (e), consistent with a more conservative definition of a cluster which would then require more onward transmission.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“From 1 June 2020 to 30 September 2020, the Swiss Federal Office of Public Health (FOPH) reported 23,199 confirmed SARS-CoV-2 cases.14,583 (62.9%) cases provided information about their likely place of exposure and country of infection in a clinical registration form.Of these, 3,304 (22.7%) reported an exposure abroad and 136 (0.9%) named Spain as the country of infection.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Estimation of contributions from imports
plainn = 23,199- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After sub-sampling, the 20E (EU1) cluster within the Nextstrain build contains 5,145 sequences, 3,369 of which are unique (accounting for Ns).”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Phylogenetic analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Switzerland reported 131 infections in travel returnees, while the model predicts 130.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Travel resumed quickly and peaked during July and August, see Fig. 3.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The substitution A222V in spike has no substantial effect on antigenic properties (a-d) and replication of pseudotyped lentiviruses (e-h).”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In Europe, we see 206 20E (EU1) singletons (46% of all 20E (EU1) introductions).”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While initial introductions of the variant likely originated from Spain, 20E (EU1) cases outside of Spain surpassed those in Spain in late September and later cross-border transmissions likely originated in other countries (see Fig ED5 B).”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Different mutations between positions 180 and 220 in N are observed in almost every major lineage and we are not aware of any evidence suggesting that these mutations have important phenotypic consequence.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Characterization of S:A222V
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Residue S477 is close to the receptor binding site (Fig ED2) and part of the epitope recognized by the S2E12 and C102 neutralizing antibodies 17,18 .”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Abstract
What the sources say
- Not checked yetcites [17] Barnes, C. O. et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 588, 682–687 (2020). source
- Not checked yetcites [18] Tortorici, M. A. et al. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science 370, 950–957 (2020). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Despite limitations in sampling, Fig. ED4a clearly shows that most major genotypes in this cluster were distributed to multiple countries, suggesting that identical genotypes were introduced into many countries .”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: The majority of mutations observed in the tree arose once and were carried between countries.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The variant seems to have initially spread among agricultural workers in Aragon and Catalonia, then moved into the local population, where it was able to travel to the Valencia Region and on to the rest of the country.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, countries where 20E (EU1) was rare (Belgium, France, Czech Republic, Fig. ED1) have seen similarly rapid increases, suggesting that this rise was not driven by any particular lineage and that 20E (EU1) has no substantial difference in transmissibility.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The fact that the rapid increase of the frequency of 20E (EU1) slowed or stopped in most countries after the summer travel period and didn't fully replace other variants is consistent with import driven dynamics with little or no competitive advantage.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Though the jitter means branch lengths should be interpreted with caution, the smallest branches shown in the tree equal to 1 mutation.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Pseudotyped Lentivirus Production and Titering
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“It is important to remember that, particularly for countries other than the UK, the full circulating diversity of the variant is probably not being captured, thus intermediate transmissions cannot be ruled out.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Phylogeny and Geographic Distribution
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Countries like Norway and Iceland have relatively few clusters, with one or two large clusters dominating, suggesting a small number of introductions dominated 20E (EU1) circulation.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“They are not in the database of commonly misidentified cell lines.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Enzyme-linked immunosorbent assay (ELISA)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Countries with small (1-4 fold) and large (8-12 fold) discrepancies tend to visit distinct destinations in Spain, see Figs.ED6 and ED7(c-e), further suggesting that underestimation of incidence in travel returnees is determined by destination and behavior.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“This selection will exclude any sequences with no coverage or reversions at these positions, but the similarity-based sampling during the Nextstrain run will identify these, as well as any other nearby sequences, and incorporate them into the dataset.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Defining the 20E (EU1) Cluster
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Further, we excluded several problematic sequences due to high intra-sample variation, wrong dates, and over-divergence (divergence values are implausible given the provided dates).”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Defining the 20E (EU1) Cluster
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Travel precautions such as quarantine should in principle have prevented spread of SARS-CoV-2 infections acquired abroad, but in practice failed to have the desired effect.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Countries like the UK and Denmark, on the other hand, show many clusters of varying size, indicating multiple introductions that led to onward spread.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While we cannot rule out that 20E (EU1) has a slight transmission advantage compared to other variants circulating at the time, most of its spread is explained by epidemiological factors.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In case of 20E (EU1) none of these seem to have changed substantially, making it an important example of how travel combined with large regional differences in prevalence can lead to substantial rapid shifts in the variant distribution without a dramatic transmission advantage.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Discussion
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In such a high incidence setting, travel alone cannot explain a rapid rise in frequency and the dynamics points to a bona fide transmission advantage.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Discussion
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The experiment shown is representative of two independent experiments.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“This tree allows us to infer lower bounds for the number of introductions to each country, and to identify plausible origins of those introductions.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Phylogeny and Geographic Distribution
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Such association with particular demographics will decay rapidly and with it any associated increased transmission inferred by phylodynamics.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Gibco (Fisher) Expi293F Cells were used for protein production and have not been authenticated or tested for mycoplasma contamination.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Enzyme-linked immunosorbent assay (ELISA)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The authors state this as an assumption.
Returning tourists have a similar SARS-CoV-2 incidence to the reported provincial incidence in Spain.
“assuming that returning tourists have a similar incidence”
The authors state this as an assumption.
20E (EU1) spread at the same rate as other variants in the resident countries.
“This model assumes that 20E (EU1) spread at the same rate as other variants in the resident countries”
The authors state this as an assumption.
The majority of mutations observed in the tree arose once and were carried between countries.
“it is reasonable to assume that the majority of mutations observed in the tree arose once and were carried (possibly multiple times) between countries.”
The authors state this as an assumption.
Reported provincial incidence in Spain is accurate and representative for the import model.
“Taking reported incidence in the provinces at face value”
The authors state this as an assumption.
20E (EU1) and non-20E (EU1) variants share a sampling probability.
“20E (EU1) and non-20E (EU1) variants share a sampling probability”
The paper relies on this without support.
Observed frequencies are subject to variable reporting delays.
“Observed frequencies are subject to variable reporting delays.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the decline in the number of cases by June, 2020 led governments in Europe to rescind control measures and to encourage a return to life as usual, especially in the context of Europe's upcoming summer holidays; this relaxing of control measures led to another wave of infections in countries across Europe in September, 2020.”
From The Lancet Commission on lessons for the future from the COVID-19 pandemic (2022) · cites this paper as [180]
Citations
Cites
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform
Katoh, K. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf436 · Cited by 17,027
IQ-TREE 2: New models and efficient methods for phylogenetic inference in the genomic era
(2019) · doi:10.1101/849372 · Cited by 16,873
IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era
Minh, B. Q., Schmidt, H. A., Chernomor, O., Schrempf, D., Woodhams, M. D., von Haeseler, A., & Lanfear, R. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa015 · Cited by 16,873
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Self-citationBEAST 2.5: An advanced software platform for Bayesian evolutionary analysis
Bouckaert, R., Vaughan, T. G., Barido-Sottani, J., Duchêne, S., Fourment, M., Gavryushkina, A., Heled, J., Jones, G., Kühnert, D., De Maio, N., et al. (2019) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006650 · Cited by 4,556
Self-citationKorber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
Nextstrain: real-time tracking of pathogen evolutionPreprint
Hadfield, J., Megill, C., Bell, S. M., et al. (2017) · bioRxiv · doi:10.1101/224048 · Cited by 3,172
Nextstrain: real-time tracking of pathogen evolution
Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., & Neher, R. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty407 · Cited by 3,154
Self-citationGISAID: Global initiative on sharing all influenza data – from vision to reality
Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039
Research works printed but not linked: 1
- Pearson, C. A. B. et al. Estimates of severity and transmissibility of novel SARS-CoV-2 variant 501Y.V2 in South Africa. Preprint at https://cmmid.github.io/topics/covid19/sa-novel-variant.html (2021).
Cited by
Sorted by citations
Items 201–300 of 605
Mallm, J., Bundschuh, C., Kim, H., Weidner, N., Steiger, S., Lander, I., Börner, K., Bauer, K., Hübschmann, D., Beneš, V., et al. (2021) · medRxiv · doi:10.1101/2021.04.27.21254849 · Cited by 16
Analysis of SARS-COV2 spike protein variants among Iraqi isolates
Sabir, D. K. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101420 · Cited by 15
Colson, P., Delerce, J., Marion‐Paris, E., Lagier, J., Levasseur, A., Fournier, P., Scola, B. L., & Raoult, D. (2022) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2022.105360 · Cited by 15
Tracking contemporary microbial evolution in a changing ocean
Brennan, G. L., & Logares, R. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.09.001 · Cited by 15
Porter, A. F., Sherry, N. L., Andersson, P., Johnson, S. A. S., Duchêne, S., & Howden, B. P. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010415 · Cited by 15
Dispersion patterns of SARS-CoV-2 variants Gamma, Lambda and Mu in Latin America and the Caribbean
Gräf, T., Martínez, A. A., Bello, G., Dellicour, S., Lemey, P., Colizza, V., Mazzoli, M., Poletto, C., Cardoso, V. L. O., da Silva, A. F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46143-9 · Cited by 16
Yang, Y., Wang, B., Li, W., Cai, H.-L., Qian, Q.-Y., Yu, Q. P., Shi, F., Bosch, B., & Huang, Y. (2024) · Journal of Virology · doi:10.1128/jvi.00139-24 · Cited by 15
Schöfbänker, M., Günther, T., Lorentzen, E. U., Romberg, M.-L., Hennies, M. T., Neddermeyer, R., Müller, M. M., Mellmann, A., Bojarzyn, C. R., Lenz, G., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012624 · Cited by 16
Cyanobacterial natural products as sources for antiviral drug discovery against COVID-19
Porzani, S. J., Konur, O., & Nowruzi, B. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1899050 · Cited by 15
Is Omicron the last SARS-CoV-2 Variant of Concern?
Rahimi, F., & Abadi, A. T. B. (2022) · Archives of Medical Research · doi:10.1016/j.arcmed.2022.01.001 · Cited by 15
de Souza, U. J. B., dos Santos, R. N., de Melo, F. L., Belmok, A., Galvão, J. D., de Rezende, T. C. V., Cardoso, F. D. P., Carvalho, R. F., Oliveira, M. D. S., Júnior, J. C. R., et al. (2022) · Viruses · doi:10.3390/v14040659 · Cited by 15
The phylodynamics of SARS-CoV-2 during 2020 in Finland
Nguyen, P. T., Kant, R., den Broeck, F. V., Suvanto, M. T., Alburkat, H., Virtanen, J. M. E., Ahvenainen, E., Castrén, R. S., Hong, S. L., Baele, G., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00130-7 · Cited by 22
Merhi, G., Trotter, A. J., Martins, L. D. O., Koweyes, J., Le-Viet, T., Naja, H. A. E., Albuaini, M., Prosolek, S. J., Alikhan, N.-F., Lott, M. C., et al. (2022) · Microbial Genomics · doi:10.1099/mgen.0.000838 · Cited by 15
Mondeali, M., Etemadi, A., Barkhordari, K., Kesheh, M. M., Shavandi, S., Bahavar, A., Hosseini, F., Gomari, M. M., & Modarressi, M. H. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30367 · Cited by 15
Dellicour, S., Hong, S. L., Hill, V., Dimartino, D., Marier, C., Zappile, P., Harkins, G. W., Lemey, P., Baele, G., Duerr, R., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011348 · Cited by 15
Bogdan, I. G., Reddyreddy, A. R., Nelluri, A., Maganti, R. K., Bratosin, F., Fericean, R. M., Dumitru, C., Barata, P. I., Tapalaga, G., & Marincu, I. (2023) · Medicina · doi:10.3390/medicina59071253 · Cited by 16
No detectable signal for ongoing genetic recombination in SARS-CoV-2Preprint
Richard, D., Owen, C. J., van Dorp, L., & Balloux, F. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.15.422866 · Cited by 15
Mohapatra, R. K., Mishra, S., Kandi, V., Branda, F., Ansari, A., Rabaan, A. A., & Kudrat‐E‐Zahan, M. (2023) · Health Science Reports · doi:10.1002/hsr2.1596 · Cited by 14
Sobral, A. F., Dinis‐Oliveira, R. J., & Barbosa, D. J. (2024) · Forensic Science International Genetics · doi:10.1016/j.fsigen.2024.103163 · Cited by 14
Galmiche, S., Coustaury, C., Charniga, K., Grant, R., Cauchemez, S., Fontanet, A. L., The Western European Covid-19 Excess Mortality Working Group, Autran, B., Barnbrook, M., Barros, H., et al. (2024) · BMC Global and Public Health · doi:10.1186/s44263-024-00103-z · Cited by 15
Self-citationCapozzi, L., Bianco, A., Sambro, L. D., Simone, D., Lippolis, A., Notarnicola, M., Pesole, G., Pace, L., Galante, D., & Parisi, A. (2021) · Viruses · doi:10.3390/v13050731 · Cited by 14
SARS-CoV-2 Variants in Lebanon: Evolution and Current Situation
Fayad, N., Habib, W. A., Kandeil, A., El‐Shesheny, R., Kamel, M. N., Mourad, Y., Mokhbat, J., Kayali, G., Goldstein, J., & Abdallah, J. (2021) · Biology · doi:10.3390/biology10060531 · Cited by 15
García‐Vidal, C., Iglesias‐Caballero, M., Puerta‐Alcalde, P., Más, V., Cuesta, G., García-Pouton, N., Varona, S., Pozo, F., Vázquez‐Morón, S., Marcos, M. Á., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.826883 · Cited by 14
Self-citationArana, C., Liang, C., Brock, M., Zhang, B., Zhou, J., Chen, L., Cantarel, B. L., SoRelle, J. A., Hooper, L. V., & Raj, P. (2022) · PLoS ONE · doi:10.1371/journal.pone.0261014 · Cited by 17
Chakraborty, C., Sharma, A. R., Bhattacharya, M., Agoramoorthy, G., & Lee, S. (2022) · Aging and Disease · doi:10.14336/ad.2021.1117 · Cited by 14
Disease Waves of SARS-CoV-2 in Iran Closely Mirror Global Pandemic Trends
Fattahi, Z., Mohseni, M., Beheshtian, M., Jafarpour, A., Jalalvand, K., Keshavarzi, F., Behravan, H., Ghodratpour, F., Ashrafi, F. Z., Kalhor, M., et al. (2022) · Archives of Iranian Medicine · doi:10.34172/aim.2022.83 · Cited by 14
SARS-CoV-2 Infection During the First and Second Pandemic Waves in Spain: the ENE–COVID Study
Pérez‐Gómez, B., Pastor‐Barriuso, R., Fernández‐de‐Larrea, N., Hernán, M. Á., Pérez‐Olmeda, M., Oteo, J., Fernández‐Navarro, P., Fernández-García, A., Martín, M., Cruz, I., et al. (2023) · American Journal of Public Health · doi:10.2105/ajph.2023.307233 · Cited by 14
Yang, L., Wang, Z., Wang, L., Vrancken, B., Wang, R., Wei, Y., Rader, B. M., Wu, C., Chen, Y., Wu, P., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2305403120 · Cited by 14
Hinch, R., Panovska‐Griffiths, J., Probert, W. J. M., Luca Ferretti, A., Wymant, C., Lauro, F. D., Baya, N. A., Ghafari, M., Abeler‐Dörner, L., The COVID-19 Genomics UK (COG-UK) Consortium, et al. (2022) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2021.0304 · Cited by 14
Detection of the novel SARS-CoV-2 European lineage B.1.177 in Ontario, Canada
Guthrie, J. L., Teatero, S., Zittermann, S. I., Chen, Y., Sullivan, A., Rilkoff, H., Joshi, E., Sivaraman, K., de Borja, R., Sundaravadanam, Y., et al. (2021) · Journal of Clinical Virology Plus · doi:10.1016/j.jcvp.2021.100010 · Cited by 13
Baron, Y. M. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110718 · Cited by 13
Detection of SARS-CoV-2 in a dog with hemorrhagic diarrhea
Padilla‐Blanco, M., Vega, S., Enjuanes, L., Morey, A., Lorenzo-Bermejo, T., Marín, C., Ivorra, C., Maiques, E., Rubio, V., & Rubio‐Guerri, C. (2022) · BMC Veterinary Research · doi:10.1186/s12917-022-03453-8 · Cited by 13
Khetran, S. R., & Mustafa, R. (2023) · JMIR Bioinformatics and Biotechnology · doi:10.2196/43906 · Cited by 13
Human gut microbiota composition associated with international travels
Henares, D., Monsálvez, V., Brotons, P., Machado, M. L., Capilla, S., Grange, A. G., Bierge, P., Cubero, M., Pich, Ò. Q., Requena‐Méndez, A., et al. (2024) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2024.102747 · Cited by 13
Hall, M. D., Baruch, J., Carson, G., Citarella, B. W., Dagens, A., Dankwa, E. A., Donnelly, C. J., Dunning, D. J., Escher, M., Kartsonaki, C., et al. (2021) · eLife · doi:10.7554/elife.70970 · Cited by 13
Nunes, D. R., Braconi, C. T., Ludwig‐Begall, L. F., Arns, C. W., & Durães‐Carvalho, R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268389 · Cited by 14
Estimation of R0 for the spread of SARS-CoV-2 in Germany from excess mortality
Prada, J. P., Maag, L. E., Siegmund, L., Bencúrová, E., Liang, C., Koutsilieri, E., Dandekar, T., & Scheller, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-22101-7 · Cited by 13
The newly introduced SARS-CoV-2 variant A222V is rapidly spreading in Lazio region, ItalyPreprint
Bartolini, B., Rueca, M., Gruber, C. E. M., Messina, F., Giombini, E., Ippolito, G., Capobianchi, M. R., & Di, A. (2020) · medRxiv · doi:10.1101/2020.11.28.20237016 · Cited by 13
SARS-CoV-2 epidemiology, kinetics, and evolution: A narrative review
Alizon, S., & Sofonea, M. T. (2025) · Virulence · doi:10.1080/21505594.2025.2480633 · Cited by 14
Fernández‐Nieto, D., Ortega-Quijano, D., Suárez‐Valle, A., Jimenez‐Cauhe, J., Jaén‐Olasolo, P., & Fernández-Guarino, M. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17051 · Cited by 12
Disparities in the Evolution of the COVID-19 Pandemic between Spanish Provinces
López-Mendoza, H., Montañés, A., & Moliner-Lahoz, F. J. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18105085 · Cited by 12
Yi, B., Poetsch, A. R., Stadtmüller, M., Rost, F., Winkler, S., & Dalpke, A. H. (2021) · Epidemiology and Infection · doi:10.1017/s0950268821001461 · Cited by 12
Wu, L., Baylan, U., van der Leeden, B., Schurink, B., Roos, E., Schalkwijk, C. G., Bugiani, M., van der Valk, P., van Rossum, A. C., Zeerleder, S. S., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.11.079 · Cited by 12
Gargouri, S., Souissi, A., Abid, N., Chtourou, A., Fki‐Berrajah, L., Karray, R., Kossentini, H., Ayed, I. B., Abdelmoula, F., Chakroun-Walha, O., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.01.006 · Cited by 12
The COVID-19 wave in Belgium during the Fall of 2020 and its association with higher education
Natalia, Y. A., Faes, C., Neyens, T., & Molenberghs, G. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264516 · Cited by 12
Kloping, Y. P., Hidayatullah, F., Rahman, Z. A., Chung, E., & Hakim, L. (2022) · The World Journal of Men s Health · doi:10.5534/wjmh.220019 · Cited by 12
Kodchakorn, K., & Kongtawelert, P. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277745 · Cited by 12
Overlapping of Independent SARS-CoV-2 Nosocomial Transmissions in a Complex Outbreak
Pérez‐Lago, L., Martínez-Lozano, H., Pajares-Díaz, J. A., Gómez, A. D., Machado, M., Sola‐Campoy, P. J., Herránz, M., Valerio, M., Olmedo, M., Suárez‐González, J., et al. (2021) · mSphere · doi:10.1128/msphere.00389-21 · Cited by 12
Self-citationGonzález-Puelma, J., Aldridge, J., de, M. M., Pinto, M., Uribe-Paredes, R., Fernández-Goycoolea, J., Álvarez-Saravia, D., Álvarez, H., Encina, G., Weitzel, T., et al. (2021) · Viruses · doi:10.3390/v13050883 · Cited by 12
Emerging SARS-CoV-2 Diversity Revealed by Rapid Whole-Genome Sequence Typing
Moustafa, A. M., & Planet, P. J. (2021) · Genome Biology and Evolution · doi:10.1093/gbe/evab197 · Cited by 12
SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
Duerr, R., Crosse, K. M., Valero-Jimenez, A. M., & Dittmann, M. (2021) · Microorganisms · doi:10.3390/microorganisms9071389 · Cited by 12
Potential zoonotic spillover at the human–animal interface: A mini-review
Fauziah, I., Nugroho, H. A., Yanthi, N. D., Tiffarent, R., & Saputra, S. (2024) · Veterinary World · doi:10.14202/vetworld.2024.289-302 · Cited by 11
Yu, Q., Ascensao, J. A., Okada, T., Boyd, O., Volz, E., & Hallatschek, O. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012090 · Cited by 11
Strain-level transmission inference across multi-kingdom metagenomic data using TRACS
Tonkin‐Hill, G. Q., Shao, Y., Zarebski, A. E., Mallawaarachchi, S., Xie, O., Mäklin, T., Thorpe, H. A., Davies, M. R., Bentley, S. D., Lawley, T. D., et al. (2026) · Nature Microbiology · doi:10.1038/s41564-026-02339-x · Cited by 11
Goyal, M., Bruyne, K. D., van Belkum, A., & West, B. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104730 · Cited by 12
Leach, A., Miller, A., Bentley, E. M., Mattiuzzo, G., Thomas, J. C., McAndrew, C., van Montfort, R., & Rabbitts, T. H. (2021) · Scientific Reports · doi:10.1038/s41598-021-89887-w · Cited by 11
Molecular epidemiology of SARS-CoV-2 in Cyprus
Richter, J., Fanis, P., Tryfonos, C., Koptides, D., Krashias, G., Bashiardes, S., Hadjisavvas, A., Loizidou, M. A., Oulas, A., Alexandrou, D., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248792 · Cited by 11
Osnes, M. N., Alfsnes, K., Bråte, J., García, I., Riis, R. K., Instefjord, K. H., Elshaug, H., Vollan, H. S., Moen, L. V., Pedersen, B. N., et al. (2021) · Virus Evolution · doi:10.1093/ve/veab086 · Cited by 11
Dolci, M., Signorini, L., Cason, C., Campisciano, G., Kunderfranco, P., Pariani, E., Galli, C., Petix, V., Ferrante, P., Delbue, S., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10030612 · Cited by 11
Wittkowski, K. M. (2022) · Cureus · doi:10.7759/cureus.29146 · Cited by 11
Steinberg, A. P., Silander, O., & Kussell, E. L. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2206945119 · Cited by 11
Дмитриевна, М. А., Klink, G. V., Safina, K. R., Nabieva, E., Garushyants, S. K., Biba, D., Bazykin, G. A., Mikhaylov, I. M., Say, A. V., Zakamornaya, A. I., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285664 · Cited by 11
The necropolitics of expendability: migrant farm workers during COVID-19
Kotsila, P., & Argüelles, L. (2023) · The Journal of Peasant Studies · doi:10.1080/03066150.2023.2243440 · Cited by 11
Sobek, E. A., & Elias, D. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293504 · Cited by 12
Ömer, Ş., & Kübra, Ş. (2021) · Journal of Genetics and Genome Research · doi:10.23937/2378-3648/1410053 · Cited by 11
A Comparative Study of the First and Second Waves of COVID-19 in Hemodialysis Patients From Pakistan
Rahim, S., Dhrolia, M. F., Qureshi, R., Nasir, K., & Ahmad, A. (2022) · Cureus · doi:10.7759/cureus.21512 · Cited by 11
Population Genomics Approaches for Genetic Characterization of SARS-CoV-2 Lineages
Mostefai, F., Gamache, I., N’Guessan, A., Pelletier, J., Huang, J., Murall, C. L., Pesaranghader, A., Gaonac’h-Lovejoy, V., Hamelin, D. J., Poujol, R., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.826746 · Cited by 11
SARS-CoV-2 gained a novel spike protein S1–N-Terminal Domain (S1-NTD)
Desingu, P. A., Nagarajan, K., & Dhama, K. (2022) · Environmental Research · doi:10.1016/j.envres.2022.113047 · Cited by 11
Assessing the Impact of SARS-CoV-2 Lineages and Mutations on Patient Survival
Loucera, C., Pérez-Florido, J., Casimiro‐Soriguer, C. S., Ortuño, F. M., Carmona, R., Bostelmann, G., Martínez-González, L. J., Muñoyerro-Muñiz, D., Villegas, R., Rodríguez‐Baño, J., et al. (2022) · Viruses · doi:10.3390/v14091893 · Cited by 11
Self-citationGhio, D., Goujon, A., & Bosco, C. (2024) · Population Space and Place · doi:10.1002/psp.2848 · Cited by 10
Mah, M. G., Zeller, M. A., Zhang, R., Zhuang, Y., Maro, V. P., Crump, J. A., Rubach, M. P., Ooi, E. E., Low, J. G. H., Wang, D. Y., et al. (2024) · npj Viruses · doi:10.1038/s44298-024-00058-w · Cited by 10
Rego, N., Salazar, C., Paz, M., Costábile, A., Fajardo, Á., Ferrés, I., Perbolianachis, P., Fernández-Calero, T., Noya, V., Machado, M. R., et al. (2021) · Viruses · doi:10.3390/v13091801 · Cited by 11
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2
Saunders, N., Planas, D., Bolland, W., Rodriguez, C., Fourati, S., Buchrieser, J., Planchais, C., Prot, M., Staropoli, I., Guivel‐Benhassine, F., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103934 · Cited by 13
Chan, F. H. M., Ataíde, R., Richards, J. S., & Narh, C. A. (2022) · Viruses · doi:10.3390/v14071434 · Cited by 10
CovRadar: continuously tracking and filtering SARS-CoV-2 mutations for genomic surveillance
Wittig, A., Miranda, F. M., Hölzer, M., Altenburg, T., Bartoszewicz, J. M., Beyvers, S., Dieckmann, M. A., Genske, U., Giese, S. H., Nowicka, M., et al. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac411 · Cited by 11
Genomic evolution of SARS-CoV-2 in Reunion Island
Wilkinson, D. A., Mercier, A., Turpin, M., Simbi, M.-A., Turpin, J., Lebarbenchon, C., Césari, M., Jaffar‐Bandjee, M., Josset, L., Yemadje, L., et al. (2022) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2022.105381 · Cited by 10
Mze, N. P., Kacel, I., Beye, M., Tola, R., Sarr, M., Basco, L. K., Bogreau, H., Colson, P., & Fournier, P. (2023) · Genes · doi:10.3390/genes14030681 · Cited by 10
HaploCoV: unsupervised classification and rapid detection of novel emerging variants of SARS-CoV-2
Chiara, M., Horner, D. S., Ferrandi, E., Gissi, C., & Pesole, G. (2023) · Communications Biology · doi:10.1038/s42003-023-04784-4 · Cited by 10
Rothstein, A. P., Jesser, K. J., Feistel, D. J., Konstantinidis, K. T., Trueba, G. A., & Lévy, K. (2023) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2023.105476 · Cited by 10
Genomic epidemiological analysis of SARS-CoV-2 household transmission
Hare, D., González, G., Dean, J., McDonnell, K., Carr, M. J., & Gascun, C. F. D. (2021) · Access Microbiology · doi:10.1099/acmi.0.000252 · Cited by 10
Persistence of infectious SARS‐CoV‐2 particles for up to 37 days in patients with mild COVID‐19
Zahn, T. R., Mhedhbi, I., Hein, S., Raupach, J., Miskey, C., Husria, Y., Bayanga, K., Bartel, D., Vieths, S., Ivics, Z., et al. (2021) · Allergy · doi:10.1111/all.15138 · Cited by 11
Zuil, M., Benitez, I. D., Cabo-Gambín, R., Senra, C. M., Moncusí‐Moix, A., Gort‐Paniello, C., de Gonzalo‐Calvo, D., Molinero, M., Aragoncillo, J. J. V., Comella, T., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258918 · Cited by 10
SNP and Phylogenetic Characterization of Low Viral Load SARS-CoV-2 Specimens by Target Enrichment
Orf, G. S., Forberg, K., Meyer, T. V., Mowerman, I., Mohaimani, A., Faron, M. L., Jennings, C., LANDAY, A. L., Goldstein, D., Fox, A. S., et al. (2021) · Frontiers in Virology · doi:10.3389/fviro.2021.765974 · Cited by 10
Rapid and sensitive detection of SARS-CoV-2 variants in nasopharyngeal swabs and wastewaters
D’Agostino, Y., Rocco, T., Ferravante, C., Porta, A., Tosco, A., Cappa, V. M., Lamberti, J., Alexandrova, E., Memoli, D., Terenzi, I., et al. (2022) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115632 · Cited by 10
Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in SwitzerlandPreprint
Chen, C., Nadeau, S., Topolsky, I., Manceau, M., Huisman, J. S., Jablonski, K. P., Fuhrmann, L., Dreifuss, D., Jahn, K., Beckmann, C., et al. (2021) · medRxiv · doi:10.1101/2021.03.05.21252520 · Cited by 10
Self-citationThe Tortoise and the Hare: The Race between Vaccine Rollout and New Covid Variants
Turner, D. D., Guillemette, Y., Egert, B., & Botev, J. (2021) · OECD Economics Department working papers · doi:10.1787/4098409d-en · Cited by 10
Signs and symptoms of COVID‐19 in patients with multiple sclerosis
Schiavetti, I., Carmisciano, L., Ponzano, M., Cordioli, C., Cocco, E. E., Marfia, G. A., Inglese, M., Filippi, M., Radaelli, M., Bergamaschi, R., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15554 · Cited by 9
CMAPLE: Efficient Phylogenetic Inference in the Pandemic Era
Ly-Trong, N., Bielow, C., Maio, N. D., & Minh, B. Q. (2024) · Molecular Biology and Evolution · doi:10.1093/molbev/msae134 · Cited by 9
Rose, E. B., Paden, C. R., Cook, P. W., Ma, K. C., Winn, A. K., Castro, J., Panagiotakopoulos, L., & Silk, B. J. (2025) · Emerging infectious diseases · doi:10.3201/eid3108.250451 · Cited by 9
Dadonaite, B., Harari, S., Larsen, B. B., Kampman, L., Harteloo, A., Elias-Warren, A., Chu, H. Y., & Bloom, J. D. (2025) · Journal of Virology · doi:10.1128/jvi.01423-25 · Cited by 11
Self-citationRate variation and recurrent sequence errors in pandemic-scale phylogenetics
Maio, N. D., Willemsen, M. S., Martin, S., Guo, Z., Saha, A., Hunt, M., Ly-Trong, N., Minh, B. Q., Iqbal, Z., & Goldman, N. (2026) · Nature Methods · doi:10.1038/s41592-025-02932-8 · Cited by 9
Caputo, E., & Mandrich, L. (2022) · Life · doi:10.3390/life12081245 · Cited by 9
Genome Structure, Life Cycle, and Taxonomy of Coronaviruses and the Evolution of SARS-CoV-2
Lamkiewicz, K., Gomez, L. R. E., Kühnert, D., & Marz, M. (2023) · Current topics in microbiology and immunology · doi:10.1007/978-3-031-15640-3_9 · Cited by 11
Vallée, A., Faranda, D., & Arutkin, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-30014-2 · Cited by 9
Genomic Surveillance of SARS-CoV-2 in Mozambique Using Pandemic-Scale Phylogenies
Martínez-Martínez, F. J., Massinga, A. J., de Jesus, Á., Ernesto, R., Cano-Jiménez, P., Chiner‐Oms, Á., Gómez-Navarro, I., Guillot-Fernández, M., Guinovart, C., Sitoe, A., et al. (2022) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00169-9 · Cited by 10
Self-citationDrivers and impact of the early silent invasion of SARS-CoV-2 Alpha
Faucher, B., Sabbatini, C. E., Czuppon, P., Kraemer, M. U. G., Lemey, P., Colizza, V., Blanquart, F., Boëlle, P., & Poletto, C. (2024) · Nature Communications · doi:10.1038/s41467-024-46345-1 · Cited by 11
High-resolution epidemiological landscape from ~290,000 SARS-CoV-2 genomes from Denmark
Khurana, M. P., Curran-Sebastian, J. L., Scheidwasser, N., Morgenstern, C., Rasmussen, M., Fonager, J., Stegger, M., Tang, M. E., Juul, J. L., Escobar-Herrera, L. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51371-0 · Cited by 9
Jun, L., Yang, J., Xue, J., Zhu, P., Liu, L., & Li, S. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-13247-4 · Cited by 9
The evolving proteome of SARS-CoV-2 predominantly uses mutation combination strategy for survival
Patro, L. P. P., Sathyaseelan, C., Uttamrao, P. P., & Rathinavelan, T. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.05.054 · Cited by 9
VirusLab: A Tool for Customized SARS-CoV-2 Data Analysis
Pinoli, P., Bernasconi, A., Sandionigi, A., & Ceri, S. (2021) · BioTech · doi:10.3390/biotech10040027 · Cited by 9
Metadata
- Authors
- Hodcroft, E. B., Zuber, M., Nadeau, S., Vaughan, T. G., Crawford, K. H. D., Althaus, C. L., Reichmuth, M. L., Bowen, J. E., Walls, A. C., Corti, D., Bloom, J. D., Veesler, D., Mateo, D., Hernando, A., Comas, I., González-Candelas, F., SeqCOVID-SPAIN consortium, González-Candelas, F., Goig, G. A., Chiner-Oms, Á., Cancino-Muñoz, I., López, M. G., Torres-Puente, M., Gomez-Navarro, I., Jiménez-Serrano, S., Ruiz-Roldán, L., Bracho, M. A., García-González, N., Martínez-Priego, L., Galán-Vendrell, I., Ruiz-Hueso, P., De Marco, G., Ferrús, M. L., Carbó-Ramírez, S., D’Auria, G., Coscollá, M., Ruiz-Rodríguez, P., Roig-Sena, F. J., Sanmartín, I., Garcia-Souto, D., Pequeno-Valtierra, A., Tubio, J. M. C., Rodríguez-Castro, J., Rabella, N., Navarro, F., Miró, E., Rodríguez-Iglesias, M., Galán-Sanchez, F., Rodriguez-Pallares, S., de Toro, M., Escudero, M. B., Azcona-Gutiérrez, J. M., Alberdi, M. B., Mayor, A., García-Basteiro, A. L., Moncunill, G., Dobaño, C., Cisteró, P., García-de-Viedma, D., Pérez-Lago, L., Herranz, M., Sicilia, J., Catalán-Alonso, P., Muñoz, P., Muñoz-Cuevas, C., Rodríguez-Rodríguez, G., Alberola-Enguidanos, J., Nogueira, J. M., Camarena, J. J., Rezusta, A., Tristancho-Baró, A., Milagro, A., Martínez-Cameo, N. F., Gracia-Grataloup, Y., Martró, E., Bordoy, A. E., Not, A., Antuori-Torres, A., Benito, R., Algarate, S., Bueno, J., del Pozo, J. L., Boga, J. A., Castelló-Abietar, C., Rojo-Alba, S., Alvarez-Argüelles, M. E., Melon, S., Aranzamendi-Zaldumbide, M., Vergara-Gómez, A., Fernández-Pinero, J., Martínez, M. J., Vila, J., Rubio, E., Peiró-Mestres, A., Navero-Castillejos, J., Posada, D., Valverde, D., Estévez-Gómez, N., Fernandez-Silva, I., de Chiara, L., Gallego-García, P., Varela, N., Moreno, R., Tirado, M. D., Gomez-Pinedo, U., Gozalo-Margüello, M., Eliecer-Cano, M., Méndez-Legaza, J. M., Rodríguez-Lozano, J., Siller, M., Pablo-Marcos, D., Oliver, A., Reina, J., López-Causapé, C., Canut-Blasco, A., Hernáez-Crespo, S., Cordón, M. L. A., Lecároz-Agara, M.-C., Gómez-González, C., Aguirre-Quiñonero, A., López-Mirones, J. I., Fernández-Torres, M., Almela-Ferrer, M. R., Gonzalo-Jiménez, N., Ruiz-García, M. M., Galiana, A., Sanchez-Almendro, J., Cilla, G., Montes, M., Piñeiro, L., Sorarrain, A., Marimón, J. M., Gomez-Ruiz, M. D., López-Hontangas, J. L., González Barberá, E. M., Navarro-Marí, J. M., Pedrosa-Corral, I., Sanbonmatsu-Gámez, S., Pérez-González, C., Chamizo-López, F., Bordes-Benítez, A., Navarro, D., Albert, E., Torres, I., Gascón, I., Torregrosa-Hetland, C. J., Pastor-Boix, E., Cascales-Ramos, P., Fuster-Escrivá, B., Gimeno-Cardona, C., Ocete, M. D., Medina-Gonzalez, R., González-Cantó, J., Martínez-Macias, O., Palop-Borrás, B., de Toro, I., Mediavilla-Gradolph, M. C., Pérez-Ruiz, M., González-Recio, Ó., Gutiérrez-Rivas, M., Simarro-Córdoba, E., Lozano-Serra, J., Robles-Fonseca, L., de Salazar, A., Viñuela-González, L., Chueca, N., García, F., Gómez-Camarasa, C., Carvajal, A., de la Puente, R., Martín-Sánchez, V., Fregeneda-Grandes, J.-M., Molina, A. J., Argüello, H., Fernández-Villa, T., Farga-Martí, M. A., Domínguez-Márquez, V., Costa-Alcalde, J. J., Trastoy, R., Barbeito-Castiñeiras, G., Coira, A., Pérez-del-Molino, M. L., Aguilera, A., Planas, A. M., Soriano, A., Fernandez-Cádenas, I., Pérez-Tur, J., Marcos, M. Á., Moreno-Docón, A., Viedma, E., Mingorance, J., Galán-Montemayor, J. C., Parra-Grande, M., Stadler, T., & Neher, R. A.
- Affiliations
- University of Bern (CH)
- University of Basel (CH)
- SIB Swiss Institute of Bioinformatics (CH)
- University of Washington (US)
- Vir Biotechnology (Switzerland) (CH)
- Howard Hughes Medical Institute (US)
- Consejo Superior de Investigaciones Científicas (ES)
- Universitat de València (ES)
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (ES)
- Universitat Autònoma de Barcelona (ES)
- Hospital de Sant Pau (ES)
- Hospital Clínic de Barcelona (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Hospital San Pedro de Alcántara (ES)
- Universidad de Zaragoza (ES)
- Hospital Universitario Miguel Servet (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
- Hospital Clínico Universitario Lozano Blesa (ES)
- Servicio Gallego de Salud (ES)
- Universidade de Vigo (ES)
- Marqués de Valdecilla University Hospital (ES)
- Health Research Institute of the Balearic Islands (ES)
- Hospital Universitario Son Espases (ES)
- Osakidetza (ES)
- Hospital General Universitario de Elche (ES)
- Biogipuzkoa Health Research Institute (ES)
- Instituto de Investigación Biosanitaria de Granada (ES)
- Hospital Universitario de Gran Canaria Doctor Negrín (ES)
- INCLIVA Health Research Institute (ES)
- Hospital General de Elda (ES)
- Hospital General Universitario De Valencia (ES)
- Hospital Regional Universitario de Málaga (ES)
- Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (ES)
- Hospital General Universitario de Albacete (ES)
- Universidad de León (ES)
- Hospital Arnau de Vilanova (ES)
- Complejo Hospitalario Universitario de Santiago (ES)
- Hospital Universitario 12 De Octubre (ES)
- Hospital Universitario La Paz (ES)
- Hospital Universitario Ramón y Cajal (ES)
- Hospital Marina Baixa (ES)
- Corresponding author
- Hodcroft, Emma B.
- Neher, Richard A.
- ORCID
- Hodcroft, Emma B.
- Zuber, Moira
- Nadeau, Sarah
- Vaughan, Timothy G.
- Crawford, Katharine H. D.
- Althaus, Christian L.
- Reichmuth, Martina L.
- Bowen, John E.
- Walls, Alexandra C.
- Corti, Davide
- Bloom, Jesse D.
- Veesler, David
- Mateo, David
- Hernando, Alberto
- Comas, Iñaki
- López, Mariana Gabriela
- Jiménez-Serrano, Santiago
- Bracho, María Alma
- Ruiz-Hueso, Paula
- Carbó-Ramírez, Sandra
- D’Auria, Giuseppe
- Coscollá, Mireia
- Ruiz-Rodríguez, Paula
- Sanmartín, Isabel
- Navarro, Ferrán
- Miró, Elisenda
- Mayor, Alfredo
- Moncunill, Gemma
- Dobaño, Carlota
- Cisteró, Pau
- Sicilia, Jon
- Camarena, Juan José
- Rezusta, Antonio
- Tristancho-Baró, Alexander
- Milagro, Ana
- Martró, Elisa
- Bordoy, Antoni E.
- Not, Anna
- Benito, Rafael
- Algarate, Sonia
- Bueno, Jessica
- Martínez, Miguel J.
- Peiró-Mestres, Aida
- Posada, David
- Valverde, Diana
- Varela, Nair
- Gozalo-Margüello, Mónica
- Méndez-Legaza, José Manuel
- Siller, María
- Oliver, Antonio
- Reina, Jordi
- López-Causapé, Carla
- Aguirre-Quiñonero, Amaia
- Almela-Ferrer, Maria Rosario
- Gonzalo-Jiménez, Nieves
- Galiana, Antonio
- Cilla, Gustavo
- Montes, Milagrosa
- Piñeiro, Luis
- Sorarrain, Ane
- Marimón, José María
- Pedrosa-Corral, Irene
- Chamizo-López, Francisco
- Navarro, David
- Albert, Eliseo
- Torres, Ignacio
- Gimeno-Cardona, Concepción
- Medina-Gonzalez, Rafael
- Palop-Borrás, Begoña
- Pérez-Ruiz, Mercedes
- González-Recio, Óscar
- Chueca, Natalia
- Carvajal, Ana
- Molina, Antonio José
- Argüello, Héctor
- Costa-Alcalde, José Javier
- Trastoy, Rocío
- Coira, Amparo
- Aguilera, Antonio
- Planas, Anna M.
- Viedma, Esther
- Mingorance, Jesús
- Parra-Grande, Mónica
- Stadler, Tanja
- Neher, Richard A.
- Venue
- Nature
- Published
- 2021-06-07
- Volume
- 595
- Issue
- 7869
- Pages
- 707-712
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W3166766123
- Semantic Scholar
- 2469490cde7d14d5793b659c17202c99169479ec
- Cited by
- 425
- References
- 47
- Citations by year
- 2026: 12 · 2025: 34 · 2024: 53 · 2023: 80 · 2022: 128 · 2021: 115
- FWCI
- 29.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- edoc (University of Basel) (acceptedVersion)
- Buleria (Universidad de León) (submittedVersion, cc-by-nc-nd)
- RePEc: Research Papers in Economics (submittedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion, other-oa)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, other-oa)
- Zaguan (University of Zaragoza Repository) (submittedVersion, cc-by)
- Funders
- National Science Foundation
- Howard Hughes Medical Institute
- Burroughs Wellcome Fund
- Universität Basel
- Fast Grants
- European Commission (HORIZON2020, 101003688, COVID-19)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (196046, 196267)
- Bundesamt für Gesundheit
- Eidgenössische Technische Hochschule Zürich
- Consejo Superior de Investigaciones Científicas
- Instituto de Salud Carlos III (COV20, COV20/00140)
- National Institute of General Medical Sciences (R01GM120553)
- National Institute of Allergy and Infectious Diseases (HHSN272201700059C, COVID-19, DP1AI158186, F30AI149928, R01AI141707)
- H2020 European Research Council (638553)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Keywords
- SARS-CoV-2, COVID-19 pandemic, international travel, viral spread, genomic surveillance, travel restrictions, containment strategies, transmissibility, summer 2020, Europe, Spain
- MeSH terms
- COVID-19, SARS-CoV-2, Europe, Genotype, Humans, Phylogeny, Seasons, Time Factors, Travel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
